Drug Shortage Report for APO-MELOXICAM
Report ID | 59302 |
Drug Identification Number | 02248973 |
Brand name | APO-MELOXICAM |
Common or Proper name | MELOXICAM |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | MELOXICAM |
Strength(s) | 7.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 500 BTL |
ATC code | M01AC |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-08-27 |
Estimated end date | Unknown |
Actual end date | 2018-09-14 |
Shortage status | Resolved |
Updated date | 2019-05-21 |
Company comments | product was discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-08-27 | English | Compare |
v2 | 2018-08-27 | French | Compare |
v3 | 2018-08-28 | English | Compare |
v4 | 2019-05-21 | English | Compare |
v5 | 2019-05-21 | French | Compare |
Showing 1 to 5 of 5